Adagene (ADAG)

Adagene (ADAG) Stock Price & Analysis


ADAG Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.90 - $4.43
Previous Close$1.37
Average Volume (3M)25.28K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Mar 30, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares Outstanding43,252,567
10 Day Avg. Volume11,648
30 Day Avg. Volume25,280
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)0.58
Price to Sales (P/S)16.54
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-1.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside244.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Adagene’s price range in the past 12 months?
Adagene lowest stock price was $0.90 and its highest was $4.43 in the past 12 months.
    What is Adagene’s market cap?
    Currently, no data Available
    When is Adagene’s upcoming earnings report date?
    Adagene’s upcoming earnings report date is Mar 30, 2023 which is tomorrow.
      How were Adagene’s earnings last quarter?
      Adagene released its earnings results on Aug 30, 2022. The company reported -$0.77 earnings per share for the quarter, missing the consensus estimate of -$0.53 by -$0.24.
        Is Adagene overvalued?
        According to Wall Street analysts Adagene’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Adagene pay dividends?
          Adagene does not currently pay dividends.
          What is Adagene’s EPS estimate?
          Adagene’s EPS estimate is -$0.66.
            How many shares outstanding does Adagene have?
            Adagene has 43,794,080 shares outstanding.
              What happened to Adagene’s price movement after its last earnings report?
              Adagene reported an EPS of -$0.77 in its last earnings report, missing expectations of -$0.53. Following the earnings report the stock price went down -0.68%.
                Which hedge fund is a major shareholder of Adagene?
                Currently, no hedge funds are holding shares in ADAG


                Adagene Stock Smart Score

                The Adagene stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description


                Adagene Inc is a clinical-stage immunotherapy company focused on the design and discovery of antibodies for the treatment of cancer.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Burning Rock Biotech
                Gracell Biotechnologies
                Genetron Holdings

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis